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Abstract

Mass spectrometry (MS) has become the foremost detection method in protein analysis.
In order to realize the sensitivity levels mass spectrometers are capable of, analytes must
be purified from other components in the sample. This has become especially important
with the trend toward miniaturization and development of microfluidic and lab-on-a-chip
devices. In this thesis two sample preparation techniques for application in studying
phosphorylated peptides were investigated using capillary electrophoresis. The first
technique investigated a novel approach of integrating sample purification and
preconcentration with the coupling of selective sample injection, based on the isoelectric
point of the analytes, and enrichment using a pH junction. The integration of the two
methods was successful. The second technique investigated miniaturization of a methyl
esterification reaction. This reaction is commonly used when studying phosphorylated
peptides to reduce the non-specific binding of acidic peptides during affinity
chromatography. The reaction conditions were optimized and performed inside a
capillary.

Keywords: capillary electrophoresis, sample preparation, isoelectric point,
preconcentration, phospholipid coating, miniaturization, methyl esterification, protein
phosphorylation
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Chapter 1: Introduction to Capillary Electrophoresis and Mass
Spectrometry in Protein Analysis

2

1.1 Protein Analysis

The sequencing of the genome has led to the study of other ‘omics’ fields due, in
part, to the application of techniques developed for genomics to these other ‘omics’
fields. One of the most studied ‘omics’ fields is described by the set of proteins coded by
the genome, called the proteome, with the study of the proteome called proteomics [2],
Studying the proteome of an organism is a much more difficult and complex task than
studying the genome because the proteome is dynamic unlike the genome which is static.
There is a large range in protein expression levels (i.e. concentration of proteins).
Additionally, the expression level of a protein can vary greatly depending on stressors
(ex: temperature changes, infection, UV radiation, etc) [3, 4], In addition, once proteins
are synthesized they can be modified in many different ways [5], Sequencing and
understanding the proteome holds the key to individual protein function, unraveling
molecular pathways involved in cellular responses, as well as identifying biomarkers for
disease [6-10].
One of the first methods used to sequence proteins was the Edman degradation
[11, 12]. Briefly, this method involves the cleavage of the N-terminal amino acid. The
newly cleaved amino acid is loaded onto a chromatography column and then identified by
comparing the retention time to standard amino acids. This method is repeated until the
entire protein is sequenced. Even though this method is quite simple, there are several
drawbacks: it is very time consuming, sequencing of proteins larger than 50 amino acids
is difficult, the protein sample must be very pure, and if the N-terminus is modified the
procedure will not work [13].

Advances in mass spectrometry (MS) over the last twenty-five years have made
this the detection method of choice for proteomics research. The main reason for this is
the development of two ionization techniques: electrospray ionization (ESI) [14-16] and
matrix assisted laser desorption/ionization (MALDI) [17]. These ionization mechanisms
are considered ‘soft’ because they enable the formation of intact gas-phase ions without
fragmentation of the analyte. This allows for the collection of accurate mass information
on proteins and peptides. Earlier ionization mechanisms such as electron impact (El) and
fast atom bombardment (FAB) are considered ‘hard’ ionization mechanisms and result in
extensive fragmentation of the analyte leading to complex and difficult mass spectra to
interpret.
Mass spectrometry may give the mass of a protein but it does not directly give any
information about the identity or sequence of a protein. One approach for identifying a
protein using MS is to use an enzyme to cleave the protein at sequence specific locations.
The result is a set of peptides unique to the protein created by the chosen enzyme; this is
called the ‘peptide mass fingerprint’ (PMF). A protein can be identified by comparing
the experimental PMF with a database of theoretical PMFs of all proteins in the chosen
database [18]. The ability to identify a protein from its PMF is due to the specific nature
of the enzymatic digestion of the protein into peptides. The most commonly used
enzyme, by far, is trypsin. This enzyme cleaves the C-terminal peptide bond of two
amino acids: arginine and lysine. Other commonly used enzymes include chymotrypsin,
pepsin, endoprotinase Lys-C, and endoprotinase Asp-N.
In some cases the PMF may not give enough information to identify a protein;
there may be peaks that do not match the theoretical PMF. This may be because there are

post translational modifications (PTM) on the protein and these are not accounted for,
unless specified, in a database search. A PTM refers to changes made to the protein after
being synthesized which changes its properties. PTMs can determine the reactivity and
localization of a protein as well as how it interacts with other proteins [19]. A PTM
changes the PMF of a protein by either adding or removing functional groups from the
protein thereby changing the mass [19, 20]. Some important PTM include:
phosphorylation [21, 22], glycosylation [23, 24], methylation [25], and ubiquitination
[26]. Each PTM results in a characteristic change in the mass of the protein. In order to
characterize unknown proteins or to identify the location of a PTM the peptides from the
PMF are sequenced by being subjected to another analysis by MS followed by a database
search. This is called tandem mass spectrometry (MS/MS) and allows each peak in the
PMF to be sequenced in two steps. The first step involves isolating the peptide peak of
interest and then fragmenting the selected peptide into smaller ions using collision
induced dissociation (CID) with an inert gas (argon, nitrogen, xenon). The peptide
fragments are then directed to a second mass analyzer where they are detected based on
their mass-to-charge ratio (m/z). The fragmentation pattern can then be used to search for
the amino acid sequence corresponding to the peptide and ultimately to identify the
protein of interest.
To ensure high quality MS spectra the protein or peptide sample must be purified
prior to MS analysis. Purification removes species which would interfere with MS
detection such as salts, buffers, detergents, and surfactants. Additionally, the proteins of
interest must be separated from other proteins in the sample to reduce ion suppression. In
biological samples the concentration of proteins can vary dramatically, from a few copies
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to several thousand. During analysis with MS, proteins or peptides present in the highest
amounts tend to suppress the signals of the less abundant proteins and peptides. It is for
this reason that separation and/or fractionation steps are employed prior to MS analysis.
The most commonly used method for separation is two-dimensional gel electrophoresis
(2D-GE). The term two dimensional refers to the separation of the analytes based on two
different properties. In the first dimension proteins are separated based on their
isoelectric point (pi); this is called isoelectric focusing (IEF). The term p/refers to the
pH at which an analyte has a net neutral charge and is estimated from the pi values of
individual amino acids. The second dimension separates analytes based on their
molecular mass using a technique called sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE). The main advantage of using 2D-GE is that a large
number of proteins can be separated and visualized in a single run. However, extracting,
digesting, and MS analysis of each spot in the gel is extremely time consuming and
laborious; making high throughput analysis difficult.
An alternative to gel-base separations is high performance liquid chromatography
(HPLC). There are many different modes of HPLC which allow for multidimensional
separations of biological samples. The most commonly used modes include reversed
phase chromatography (RP), affinity chromatography, ion exchange chromatography
(cation or anion exchange), and size exclusion chromatography (SEC). HPLC is also able
to facilitate sample preparation techniques such as preconcentrating dilute samples and
on-column reactions. The sample preparation techniques can be integrated with
separation methods resulting in reduced sample consumption and sample handling.
Integrated methods are desirable because they enable automation and allow for high
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throughput analysis. In most cases the HPLC instrument is directly coupled to MS for
online analysis and increased throughput. There are some problems with HPLC: there
can be leakages due to the high pressures used, irreversible binding of proteins to the
column resulting in inefficient protein recoveries, and there is variation in the packing of
each stationary phase resulting in column-to-column variability.
A separation technique called capillary electrophoresis (CE) offers advantages
over the conventional techniques of 2D-GE and HPLC. Separation in CE is achieved by
analyte ions in solution being separated based on their charge-to-size ratios. One major
advantage CE has over 2D-GE is that much higher voltages may be used during
separation. This is due to the high surface-area-to-volume ratio which allows for very
effective dissipation of heat.

L

•

There have been several modes of CE developed, with the most commonly used
being capillary zone electrophoresis (CZE) which separates analytes based on their
charge-to-size ratio. Micellar electrokinetic chromatography (MEKC) is used to separate
neutral analytes based on their interactions with micelles of surfactant which act as a
pseudostationary phase. Capillary isoelectric focusing (CIEF) is performed by using
ampholytes to create a pH gradient and the proteins are separated based on their p/; this
mode is analogous to IEF performed in gels.
There has been a trend toward miniaturization and development of microfluidic
(and ultimately lab-on-a-chip) devices. Microfluidic devices are used to manipulate very
small volumes of fluid by using voltage and pressure to move the fluids through micro
channels etched onto the surface. A lab-on-a-chip uses microfluidics to perform an entire
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analysis on a single platform. Capillary electrophoresis has found itself in an
advantageous position when it comes to developing techniques for microfluidic devices.
This is because the use of voltage and pressure as well as the small dimensions of the
capillary makes CE ideal for developing miniaturized techniques for use on these devices.
It is here that CE has several advantages over the traditional techniques of HPLC and gel
electrophoresis. While HPLC has been used on microfluidic devices, special setup for the
use of high pressure is required which can be laborious and time consuming. Gel
electrophoresis becomes very similar to capillary gel electrophoresis (CGE) when used on
a microfluidic device due to the increased surface area-to-volume ratio.
One of the main driving forces of developing lab-on-a-chip type devices is the
desire to integrate experimental steps. Integration of sample preparation and separation
not only reduces sample handling and reagent consumption,
it also allows for automation
/
which can greatly increase throughput and reproducibility.

There has been ongoing

research into integrating sample preparation with separation steps in CE as well as
performing reactions inside the capillary. Sample preparation steps performed usually
involve enrichment of the analyte and in-capillary reactions have generally focused on
enzymatic digestions and labeling reactions [27-31].
This thesis aims to investigate sample preparation techniques using CE for
functions beyond separation. Chapter 2 investigates a combination of two previously
reported techniques which allows for selective sampling of low p/peptides followed by
enrichment and detection using MS. Chapter 3 studies an in-capillary reaction which is
commonly used in the study of phosphoproteins. The extent of the reaction is monitored
using MS.
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1.2 Theory and Instrumentation of Capillary Electrophoresis

Electrophoresis is a separation method based on the differential movement of
charged analytes in an electric field. The analytes are separated based on their, charge and
size. Traditional electrophoresis is performed in slab gels such as polyacrylamide or
agarose and is used to separate biological macromolecules. Using a gel as the medium
for separation reduces convection as well as thermal diffusion as compared to in solution.
These slab gels are one of the most commonly used separation methods in proteomics.
However, the gels suffer from poor dissipation of Joule heat; heat caused by the flow of
current through the gel. Joule heating causes band broadening which acts to decrease
resolution. Due to the heat generated, a low electric field must be used (100-300 V)
which increases run times and lowers efficiencies.

'

An alternative to slab gel electrophoresis is to perform the separation in narrowbore capillaries. The large surface area-to-volume ratio results in very efficient dissipation
of heat and thus high electric fields (up to 30 000 V) may be applied. This results in
shorter analysis times as well as high separation efficiencies. The capillary eliminates the
need to use a gel since the heat is so efficiently dissipated and generally only buffers are
present inside the capillary. The capillaries are normally made of fused silica and have an
inner diameter (i.d.) in the range of 25-100 pm, an outer diameter (o.d.) of 300-400 pm,
and are usually 40-100 cm in length. The outer surface of the capillary is coated with
polyimide to prevent breakage and also gives flexibility making the capillary easier to
work with.
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1.2.1 CE Instrumentation and Analysis

One of the advantages of capillary electrophoresis (CE) is the simplicity of the
instrumentation. Essentially all that is needed is a high voltage power source, a capillary,
two buffer reservoirs which contain both the capillary and electrodes connected to the
power supply, and a detector. A schematic of the CE setup is shown in Figure 1.1. The
most commonly used mode in CE is capillary zone electrophoresis (CZE). This
separation mode is based on differences in the charge and size ratio of the analytes. In
order to perform an analysis using CZE, the capillary must first be filled with buffer
which is done by applying pressure at the inlet buffer reservoir. The sample is then
injected by replacing the buffer at the inlet with the sample solution. The sample plug is
usually 1-2 % of the total length of the capillary and is injected hydrodynamically (with
pressure) or electrokinetically (with voltage application). Once the sample is in the
capillary, the sample reservoir is replaced with buffer and voltage is applied. The
analytes become separated based on their charge-to-size ratio and form separate sample
zones. The analytes are mobilized not only by their electrophoretic mobility, which is
based on their charge-to-size ratio, but also the electroosmotic flow (EOF, which will be
discussed in the next section) towards the cathode. The analytes are detected near the
outlet where a small window was created by burning away the polyimide coating. In
commercial CE instruments, the temperature is controlled by either thermostated air or a
liquid coolant which ensures a constant capillary temperature to avoid excessive Joule
heating.
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1.2.2 Analyte Migration in CZE

1.2.2.1 Electrophoretic Mobility (pe)

:

Separations using electrophoresis are achieved by differences in the velocities of
the analytes in an applied electric field. The electrophoretic velocity (ve) of an ion is
given by the following equation,

ve — V-e E

Equation 1.1

,

where pe represents the electrophoretic mobility of the analyte and E represents the
applied electric field, which is a function of the applied voltage and capillary length in
V/cm. In a buffer of a specific pH the electrophoretic mobility of an analyte can be
estimated using the Debye-Huckel-Henry theory,

q
~ 6 7Tr] r

Equation 1.2

where q is the charge of the ion, rj is the viscosity of the buffer, and r is the radius of the
ion (the ion is assumed to be spherical). From this equation, the electrophoretic mobility
is proportional to the charge-to-size ratio of the analyte. Generally, small highly charged
analytes will migrate with a high electrophoretic mobility whereas a large minimally
charged analyte will have low mobility.
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1.2.2.2 Electroosmotic Mobility ( peof)

The electroosmotic flow (EOF) is the bulk flow of liquid in the capillary and
results from the charged inner surface of the capillary. The EOF is responsible for how
long an analyte remains in the capillary and the EOF is additive to the electrophoretic
mobility of the analyte. In fused silica capillaries the EOF is controlled by the silanol
groups (SiOH) which can also exist in their anionic form (SiO'). Cations from the buffer
solution build up near the anionic surface, in order to maintain a charge balance, forming
a double layer (Figure 1.2) and a potential difference is created very close to the capillary
wall. This potential difference is known as the zeta potential. When voltage is applied
the cations forming the diffuse layer are attracted to the cathode. Since the cations are
solvated their movement has the effect of dragging the bulk solution in the capillary
toward the cathode, including neutral and anionic analytes.
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Figure 1.2: Illustration of the electrostatic double layer formed electrophoresis in a
fused silica capillary
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The velocity of the EOF (veof) can be expressed by the electroosmotic mobility ( peof)>

Veof

—

eof

E

Equation 1.3

£i

Equation 1.4

and
Mfof —

T1

where s is the dielectric constant and £ is the zeta potential. The zeta potential is largely
dependent on the surface charge of the inner capillary wall. Since the charge on the silica
is pH dependent, the magnitude of the EOF will vary with the pH. At high pH the silanol
groups are mainly deprotonated yielding a higher EOF than at low pH where the silanols
are protonated. The EOF is also affected by the concentration or ionic strength of the
buffer. A high ionic strength buffer reduces the zeta by compressing the diffuse layer and
thus reducing the EOF. A unique feature of the EOF is its flat flow profile as opposed to
a laminar flow which is generated in pressure driven systems (Figure 1.3). The flat
profile of the EOF is generated because the driving force (cations) of the flow is
distributed uniformly along the capillary walls resulting in less sample dispersion than
with laminar flow. The magnitude of the EOF is essentially constant across the capillary
because the thickness of the diffuse and Stem layers are negligible compared to the
diameter of the capillary.
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1
Figure 1.3: Flow profiles of A) the electoosmotic flow during electrophoresis
and B) laminar flow during liquid chromatography

1.2.3 Mobility Measurement

The mobility of an analyte in the presence of EOF is called the apparent mobility
(pa) and is based on the electrophoretic mobility (pe) as well as the electroosmotic
mobility (peof)- The apparent mobility can be expressed as the sum of the electrophoretic
and electroosmotic mobilities,
V - a — l*e

+

H-EOF

Equation 1.5

The apparent mobility is measured experimentally from the migration time of the analyte
in a CZE experiment; it is calculated as follows,

Equation 1.6
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where Ld is the distance from the inlet to the detector, t is the migration time of the
analyte from the inlet to the detector, E is the applied electric field which can be
expressed as the ratio of the applied voltage (V) and the total length of the capillary (Lt).
The units of mobility are usually cm / V s.
The mobility of the EOF can be determined by measuring the apparent mobility of
a neutral molecule (a neutral marker) whose net charge is zero. This is possible because
the neutral marker, having no net charge, is mobilized only by the EOF.

1.2.4 Protein Adsorption

One of the main issues with using fused silica is the adsorption of proteins and
peptides onto the charged inner wall. Proteins and peptides have multiple charged sites
and they interact with the silica surface by electrostatic and/or hydrophobic interactions.
Adsorption alters the EOF leading to irreproducible migration times and separations,
increased band broadening, decreased efficiency, and reduced sensitivity [32-34].
Depending on the pH of the sample, the EOF could be quite fast and sweep the analytes
past the detector before they are sufficiently separated. Thus, optimization of the EOF is
required to maximize the efficiency and resolution of separations. It is the charge on the
inner silica surface which is responsible for both adsorption of analytes and the EOF.
There are two ways to modify the EOF and control protein adsorption: either control the
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pH or ionic strength of the running buffer [35-37] or modify the physical properties of the
silica surface [38, 39].
1.2.4.1 Buffer Selection for EOF Modification and Reduction of Analyte Adsorption

One of the simplest ways to minimize analyte adsorption is to control the pH of
the buffer. The use of a low pH buffer results in protonation of the silanol groups of the
silica surface which reduces the surface charge as well as electrostatic interactions; there
is also a reduction in the magnitude of the EOF. Another approach would be to give the
analytes a negative charge reducing electrostatic attraction. This can be done by using a
buffer with pH above the p/ of the analyte [40]. However, in general as the pH increases
so does the magnitude of the EOF. One of the main drawbacks of these strategies is that
they are limited by the workable pH range as well as the tendency of the solubility and
stability of proteins and peptides to be compromised at pH extremes.
Another method to reduce analyte adsorption is to increase the ionic strength
(concentration) of the buffer. The increased ion content of the buffer also decreases the
zeta potential leading to a decrease in the magnitude of the EOF. Higher ionic strength
buffers increase the amount of Joule heating due to an increase in the current therefore a
lower field strength may need to be used. In addition, when coupling CE to mass
spectrometry (MS) a higher ionic strength buffer can have negative effects on the
sensitivity and increase ionization suppression.
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1.2.4.2 Coating the Capillary to Modify EOF and Reduce Analyte Adsorption

One of the most common methods to suppress the EOF and reduce analyte
adsorption is to cover, or coat, the inner capillary wall with a chemical. There are two
different methods to achieve this: by using either dynamic coatings or covalent coatings.

1.2.4.2.1 Covalent Coatings

These types of coatings are usually polymers which are chemically bonded to the
silica surface. Some of these coatings include polyamines [41], poly(ethyleneimine) [42],
poly(acrylamide) [43,44], cellulose derivatives [45], poly(vinyl alcohol) [46], etc.
Although these types of coatings have demonstrated high stability and reproducible
migration times their preparation is often time consuming and tedious. Sometimes
capillary-to-capillary reproduction of the coating is difficult. There are pre-coated
capillaries of this type commercially available, but they are more expensive than bare
capillaries which can greatly increase operation costs. Since these coatings are
permanently attached to the silica surface they are ideal for use with MS analysis.
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1.2.4.2.2 Dynamic Coatings

Dynamic coatings require the coating chemical to be present in the buffer during a
CE experiment. The coating chemicals absorb onto the silica surface due to electrostatic
and/or hydrophobic interactions. The coating competes with the analytes for binding sites
on the silica surface and once bound acts as a shield, reducing analyte adsorption. The
chemicals used for dynamic coatings include cationic surfactants such as polyamines [47]
and cetytrimethylammonium bromide (CTAB) [48], zwitterionic surfactants [49],
fluorosurfactants [50-52], and neutral molecules such as poly(vinyl alcohol) [46] and
polyethylene oxide) [53].
Dynamic coatings are easy to use since the chemical is added directly to the run
buffer. The coatings are generally quite stable since the coating is continually being
refreshed which yields highly reproducible and efficient separations. However, dynamic
coatings are incompatible with MS due to the presence of the coating in the buffer. There
'
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are issues with intense background peaks and ionization suppression.
In an attempt to make dynamic coatings more compatible with MS semi
permanent coatings have been developed. A semi-permanent coating differs from
dynamic coatings in that they are not required in the running buffer and thus are generally
compatible with MS. There are many different types of molecules used as semi
permanent coatings [54-56]. One class which has gained interest recently is surfactants
due to their low cost and ease of use. These molecules are amphiphilic which means they
contain a hydrophilic head group and one or more hydrophobic tails. When the
concentration of the surfactant is above the critical micelle concentration (CMC) the
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molecules aggregate to form micelles with the hydrophilic head pointing outwards and
the hydrophobic tails pointing inward (Figure 1.4 A). Double-chained surfactants have
been found to form a very stable bilayer on the silica surface (Figure 1.4 B) [57].

Figure 1.4: Structures of aggregated A) single chained surfactants and B) double
chained surfactants.
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Melanson et al. reported the use of a double chained cationic surfactant called
didodecyldimethylammonium bromide (DDAB) [58]. The DDAB molecules were shown
to form a bilayer on the silica surface (Figure 1.4 B). The DDAB coating was found to
be very stable, maintaining a stable EOF for 75 min. The separation of four cationic
proteins was highly efficient (up to 750 000 plates/m) and the authors reported
quantitative recoveries of the proteins [58]. Even though this coating was efficient at
separating cationic proteins, adsorption of anionic proteins was inevitable due to the
positively charged head (Figure 1.5 A).
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Figure 1.5: Chemical structures of some double chained surfactants. A) DDAB, Cis;
B) DLPC, Cï2; C) DMPC, CM; D) DMPA, C,4.

23
Another type of double chained surfactant which forms semi-permanent coatings
and has recently been successfully employed in highly efficient CE separations are
zwitterionic phosphatidylcholines which are a type of phospholipid. Phospholipids
possess a polar hydrophilic head group (where the phosphate and other functional groups
reside) and a double chained hydrophobic tail (Figure 1.5 B, C). These surfactants form
what is called a supported phospholipid bilayer (SPB) and are often used in membrane
studies [59-64]. The first reported use of this type of molecule as a coating in CE was
with l,2-dilauroyl-5n-phosphatidylcholine (DLPC, 2C12) (Figure 1.5 B) by Cunliffe et al.
[65]. The DLPC coating was used to separate a mixture of both cationic and anionic
proteins with very high efficiencies (up to 1.4 million plates / m). The coating was also
found to suppress the EOF and prevent adsorption of both cationic and anionic proteins
over a large pH range (pH 3-10). Another zwitterionic phospholipid similar to DLPC:
1,2-dimyristoyksYi-glycero-3-phosphocholine (DMPC, 2Cm) (Figure 1.5 C) has been
used to suppress the EOF to facilitate selective sampling of [66] and preconcentration [1]
of phosphopeptides. In Chapter 2, a solution of DMPC and an anionic phospholipid 1,2dimyristoyl-jn-glycero-3-phosphate (DMPA) (Figure 1.5 D) was used to suppress the
EOF and minimize adsorption of peptides onto the silica surface.
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1.3 Mass Spectrometry in Protein Analysis

1.3.1 Instrumentation of Mass Spectrometry

The basic components of a mass spectrometer are an ion source, a mass analyzer
and a detector. The ion source converts the analyte molecules into ions. Ionization of the
analyte typically involves the addition or removal of an electron or proton(s). The energy
transferred during ionization may fragment the analyte into characteristic fragments.
There are several methods to ionize the sample, however thè most commonly used
ionization methods in proteomics are matrix assisted laser desorption/ionization
(MALDI) and electrospray ionization (ESI). The reason these two ionization methods are
preferred in proteomic analyses is due to their 'soft ionization' mechanisms. In contrast to
other ionization mechanisms MALDI and ESI are able to generate intact gas-phase ions
from large biomolecules with little fragmentation. Once the ions are generated they move
into the mass analyzer where the ions are separated based on their mass-to-charge ratio
(m/z). There are many types of mass analyzers and the most commonly used include
time-of-flight (TOF), quadrupole (Q), Fourier-transform ion cyclotron resonance (FTICR), ion trap, and orbitrap. Mass analyzers can also be coupled together to perform
tandem mass spectrometry (MS/MS). Some common examples of MS/MS setups include
triple quadrupole (QqQ), quadrupole-time-of-flight (QTOF), and TOF-TOF.
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1.3.2 Soft Ionization Mechanisms: Electrospray Ionization and Matrix Assisted Laser
Desorption/Ionization

1.3.2.1 Electrospray Ionization

Electrospray ionization (ESI) transfers analytes from solution into gas phase ions.
The development of ESI coupled to a mass analyzer (ESI-MS) was credited to John Fenn
in 1984, for which he later received the 2002 Nobel for [15]. As the name implies, this
ionization method produces a fine spray of highly charged droplets containing the analyte
ions. The sample solution must be continuously flowing (pL/min to nL/min) through a
capillary tip which has a potential applied to it (1 - 5 kV) and is usually made from
stainless steel (Figure 1.6).

There are three major steps involved in the formation of gas

pháse ions: 1) formation of a fine mist of charged droplets from the capillary tip; 2)
shrinkage of the droplets by evaporation of the solvent (usually by a curtain of inert gas)
which leads to very small highly charged droplets; and 3) the formation of gas phase ions
from the small highly charged droplets (Figure 1.6). All three steps of ion formation
\

proceed at atmospheric pressure.
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Figure 1.6: Schematic of a CE-ESI MS interface. The sheath liquid aids in the
ionization of the CE eluent; the curtain gas is used to facilitate evaporation of the
solvent and promote the formation of gas phase ions; once formed, the gas phase ions
are directed to the mass analyzer.
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One of the main advantages of ESI is that it can be directly coupled to LC and CE
since the ionization process occurs at atmospheric pressure. When coupled to CE a
sheath flow is often used (Figure 1.6). The sheath liquid acts as the outlet buffer
reservoir for the CE experiment, ensuring electrical continuity. The sheath liquid mixes
with the CE eluent at the ESI tip and carries the eluent into the mass spectrometer. With
this setup, the CE eluent is diluted by the sheath liquid reducing sensitivity.
This ionization process generates molecular ions with multiple charges which
enables an ordinary mass analyzer (not designed for high mass analytes) to effectively
analyze very large analytes (> 10 kDa). However, multiply charged ions make the mass
spectrum difficult to analyze and interpret, especially when complex samples are used. In
addition to complex mass spectra, this ionization method is quite sensitive to the presence
of salts and detergents which may be present in the sample. These contaminants form
adducts with the analytes and can also compete for ionization. So it is important the
samples are clean before ionization.

1.3.2.2 Matrix Assisted Laser Desorption/Ionization

Matrix assisted laser desorption/ionization (MALDI) was first described in 1987
by Karas and Hillenkamp; in 1988 they analyzed the first proteins [67, 68]. This
ionization method involves mixing the protein or peptide solution with a chemical called
the matrix followed by deposition onto the MALDI target. The matrix is usually a small
organic molecule containing an aromatic region which strongly absorbs the laser light.
The solvent is allowed to dry resulting in co-crystallization of the matrix and sample. The
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target is then introduced into the vacuum of the mass spectrometer. A short laser pulse is
fired at the co-crystallized sample and matrix resulting in localized sublimation and
ionization of the matrix. Some energy absorbed by the matrix is transferred to the sample
molecules resulting in their desorption and ionization.
One of the main advantages of MALDI over ESI is that MALDI is much more
tolerant of high salt, buffer, and/or contaminant concentrations. Furthermore, MALDI
generally generates singly or doubly charged ions resulting in spectra that are easier to
interpret.

1.3.2.2.1 Sample Preparation and Matrix Selection for MALDI MS

There are several methods in which to mix the sample and the matrix. The ‘dried
droplet' method is considered by many to be the standard in MALDI sample preparation
[69, 68]. The sample and matrix are mixed together and then spotted onto the MALDI
target. The droplet is usually in the range of 0.5 - 1 pL in volume. Another deposition
technique called the 'three layer method' is often used when coupling CE to MALDI MS
[70]. The method involves spotting a thin layer of matrix crystals on the target surface.
The second layer is matrix which is more concentrated than the first layer resulting in a
thicker matrix layer. The third layer is the sample. Other commonly used sample
deposition methods for MALDI MS include the sandwich method [69], crushed crystal,
and two layer method [71].
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There are several matrices that can be used for MALDI, with the most commonly
used types shown in Figure 1.7. The matrix chosen is dependent on the type of sample
being analyzed. For example, CHCA is most often used for general proteomics analysis
while DHB is often used when studying peptides and proteins with low p/ (such as
phosphoproteins and phosphopeptides). One of the main problems associated with many
MALDI matrices is the formation of 'sweet spots’. This is where the crystallization of the
sample is not uniform throughout the matrix crystals resulting in areas with high amounts
of sample. The matrix used in this thesis is DHB since the studies are aimed at
phosphopeptides.
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Figure 1.7: Chemical structures of several common molecules used as MALDI
matrices: A) 2,5-dihydroxybenzoic acid (DHB) B) a-cyano-4-hydroxycinnamic
acid (CHCA) C) cinnamic acid D) sinapinic acid.
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1.3.3 TOF Mass Analyzer

The concept of the time of flight (TOF) mass analyzer is that ions are accelerated
through an electric field and then allowed to 'drift' through a tube at the end of which is a
detector. In practice this is achieved by accelerating all ions to a constant kinetic energy
and then measuring their flight time. With a fixed kinetic energy small ions will travel at
a higher speed than large ions as shown by:
Eklnetlc = zeV = ^ m v 2
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Where z is the charge of the ion, m is the mass of the ion, v is the velocity of the ions, e is
the electron volt (1.6xl0'19 J), V is the voltage of the pulse applied to the ion source, t is
the time it takes the ion to reach the detector, and 1 is the length of the TOF analyzer.
From these equations, ions with different m/z have different velocities (Equation
1.9) and therefore reach the detector at differing times (Equation 1.10).
One of the most important aspects of this mass analyzer is that the ions need to be
generated at a known start time and position. It is for this reason that MALDI is most
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often used with this mass analyzer. The advantages of the TOF analyzer include a
theoretically unlimited mass range, very high sensitivity due to high ion transmission, and
the instrumentation is fairly simple and straightforward. However, the resolution is
limited due to variation in ion energy.
The simplest configuration of MALDI TOF is linear mode. Once the ions are
formed they are accelerated into the drift region of the mass analyzer and then strike a
detector at the opposite end, as shown in Figure 1.8 A.
In order to address the issue of low resolution an ion mirror or reflectron can be
added (TOF-R). The reflectron uses an electrostatic field to reflect ions at an angle
towards a different detector than used in linear mode (Figure 1.8 B). Essentially, the
reflectron causes ions with the same m/z but higher kinetic energy to penetrate the ion
mirrors more deeply than those with a lower kinetic energy. This has the effect of
delaying the arrival time of the higher energy ions at the detector. The addition of the
reflectron results in improved resolution compared to linear mode. However, the
reflectron is generally only useful for peptides and small proteins (> 10,000 Da) due to
decreased sensitivity and metastable decay of larger ions. Metastable decay is due to the
unstable high mass ions which can decay during their flight in the TOF analyzer [72].
The result of metastable decay is peak broadening. In this thesis, a MALDI TOF
instrument was used in reflectron mode since the analytes were peptides (< 5,000 Da).
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Figure 1.8: Schematic of a MALDI TOF interface. A) linear detection
mode: a laser pulse desorbs and ionizes both sample and matrix molecules;
the ions drift through the TOF analyzer and are detected and B) reflectron
detection mode: same as linear mode except ion mirrors at the end of the TOF
tube redirect and focus same m/z ions with different velocities to detector.
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1.4 Coupling Capillary Electrophoresis to MALDI MS

1.4.1 Online CE MALDI MS

It is possible to couple MALDI MS in an online fashion to CE with some clever
modifications. Online CE MALDI MS is desirable due to reduced sample handling thus
reducing sample loss. Another reason is that speed and throughput would be increased
with an online approach. One reported online CE MALDI MS method involves
depositing a flow (100-400 nL/min) of sample onto a rotating quartz wheel inside the
vacuum region of the mass spectrometer [73, 74]. Once the solvent has evaporated a
trace or streak of sample is left on the wheel which is then rotated to be irradiated with the
laser. The capillary eluent is mixed with the MALDI matrix using a liquid junction
located after the window for UV detection. The authors reported a high performance
separation of a mixture of 12 peptides as well as a detection limit in the attomole range
[74].
Another online CE MALDI MS method called rotating ball interface (ROBIN)
has been reported [75, 76]. In this technique a stainless steel rotating ball is used to
introduce the eluent from the separation to the laser for analysis. The ball acts as the
cathode during the CE separation. There is another capillary filled with the running
buffer to maintain a steady current during the separation, the buffer is supplied by a
syringe pump. The matrix is deposited onto the ball by a third capillary. Unlike the
previous example, the deposition of the sample is performed at atmospheric pressure and
is then introduced to the vacuum of the mass spectrometer by rotation of the ball. Once
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the sample has been analyzed there is a felt pad soaked in solvent to remove the leftover
sample and matrix. The authors report detection limits in the high femtomole range, they
also demonstrated the separation of a mixture of peptides [75].

1.4.2 Offline CE MALDI-MS

In continuous offline CE MALDI MS the eluent is deposited onto a MALDI target
while maintaining electrical contact to allow the separation to proceed. In a method
called vacuum deposition, the end of the separation capillary is connected to a tapered
capillary which is in constant contact with the MALDI target allowing for continuous
sample deposition [77]. The tapered capillary was fed into a chamber under vacuum and
controlled with X-Y translational stages. The eluent was deposited in a 100 pm wide
trace in a zig-zag pattern on the target. After deposition of the sample, the target was
placed in a MALDI TOF mass spectrometer for analysis. The authors reported highly
reproducible signals from MALDI MS analysis, on par with what is obtained from the
V

'dry droplet’ method [77]. The benefits of continuous offline CE and MALDI steps
include no constraints on separation time or MS acquisition speed. Additionally, the
decoupled setup allows sufficient time after the initial MS analysis for selection of
specific m/z ions for MS/MS analysis. Unfortunately these modifications are not
commercially available and require significant time for setting up.
Another offline method for CE MALDI MS is to decouple the separation and
spotting steps and use pressure to spot the contents of the capillary onto the target. In this
method the voltage is suspended when the analyte reaches the end of the capillary and
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low pressure applied from the inlet is used to deposit the sample on the target. Since it
must be known when the analyte reaches the end of the capillary an online detector must
be used with this method. Due to the simplicity, this method of CE MALDI MS was used
for all mass spectrometric analyses in this thesis. The three layer matrix spotting method
was also used.

1.5 Overview of This Thesis

The main goal of this thesis is to investigate sub-microliter volume sample
preparation techniques with potential applications to phosphorylated proteins/peptides.
There were two different techniques investigated. One involved integration of two
methods previously developed by our research group: selective sampling of peptides
based on their isoelectric point (pi) followed by enrichment using a pH junction method
with discontinuous buffers (Chapter 2). In addition to enrichment it was anticipated
there would be some separation of the enriched peptides based on their pI. The second
technique investigated miniaturization of a methyl esterification reaction which is
commonly used prior to separation and/or fractionation of phosphopeptides (Chapter 3).
The esterification occurs at all carboxyl functional groups on the peptides present in the
sample solution. This has been shown to reduce non-specific binding of acidic peptides
in isolation techniques which utilize the negative charge of the phosphate to remove the
phosphopeptides from the rest of the sample. Successful miniaturization of this reaction
inside a capillary will allow its integration with devices for future development.
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Chapter 2: An Integrated Procedure of Selective Sample Injection and
Enrichment by Sample Stacking of Phosphopeptides with MALDI MS
Analysis
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2.1 Introduction

Phosphorylation is a reversible post-translational modification (PTM) involved in
many important cellular processes such as signaling, translation, regulation, and
metabolism [2]. At any one time at least 30% of proteins are thought to be
phosphorylated. With so many proteins affected by this PTM it should come as no
surprise that diseases such as cancer and diabetes have been linked to irregularities in this
PTM [3,4]. There are four types of phospho-amino acid residues: O-phosphates, Nphosphates, acylphosphates, and 5-phosphates [5], The most common type are the Ophosphates (Figure 2.1) and it is for these residues that most phosphoproteomic methods
are developed [6]. The O-phosphates include phosphorylation of the amino acids serine,
threonine, and tyrosine.

Phosphotyrosine
Figure 2.1: Chemical structures of three O-phosphates: phosphoserine,
phosphothreonine, and phosphotyrosine.
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In the study of phosphoproteins mass spectrometry (MS) has emerged as the ideal
choice for identifying phosphorylation sites. However phosphopeptides suffer from low
sensitivity in MS. The negatively charged phosphate group affects the ionization and
therefore detection of the peptide in positive ion mode; which is more sensitive than
negative ion mode. This becomes more problematic when studying peptides with
multiple phosphorylation sites. In addition, other more basic (higher p7), peptides act to
further reduce the MS signal by suppressing the ionization of the phosphorylated
peptides.
There has been considerable effort spent on enhancing the signals of
phosphopeptides in MS. It has been reported that the addition of ammonium salts, such
as ammonium citrate, to the matrix when using MALDI are effective in increasing the
signal strength of phosphopeptides [7, 8]. It is thought the ammonium ions work as
proton donors and reduce the anionic character of the phosphopeptides resulting in
increased ionization efficiency. Along the same idea of matrix additives, it has been
shown that the addition phosphoric acid to the MALDI matrix also increases the signal
strength of phosphopeptides [9,10]. The phosphoric acid was reported to improve the
incorporation of the phosphopeptides into the matrix lattice during spotting. There have
also been several reports of chemical modifications to the phosphate group [11-13]. The
phosphate group may be removed to form a lysine analog which increases the ionization
efficiency [14]. One technique which may be the simplest is to use negative ion mode in
MS analysis [15-18].
In addition to the previously mentioned techniques to increase the signals of
phosphopeptides during MS, there has been considerable effort in developing methods to
separate and isolate phosphopeptides prior to MS. The most commonly used methods are
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mainly sorption based. Immobilized metal affinity chromatography (IMAC) (using Fe ,
Ga+3, Ni+2, and Zr+4) is one of the more commonly used methods [10,19-29]; others
include metal oxide affinity chromatography (MOAC) (using TiC>2, ZrC>2, AI2O3, and
Nb205) [30-37], and ion exchange chromatography [38-41]. In these methods, the
phosphate group exhibits some affinity for the stationary phase and becomes temporarily
bound to it. The other peptides do not interact with the stationary phase and are flushed
from the column. The phosphorylated peptides are then eluted and collected and may be
further separated and/or purified before MS analysis. Even though the nonphosphorylated peptides are not supposed to bind to the stationary phase, there can be
non-specific binding of acidic peptides. Non-specific binding generally occurs with
peptides that have carboxylic acid groups on their amino acid side chains. The carboxyl
groups can interact with the stationary phase in a similar way to the phosphate group on
phosphorylated peptides. In order to reduce this non-specific binding, the sample is often
subjected to an esterification reaction which converts all carboxylic acid groups into
methyl esters [42]. While these methods have been successful in improving MS detection
of phosphopeptides there is the risk of irreversible binding resulting in sample loss. This
can be problematic when analyzing low concentration samples. Also, non-specific
binding of acidic amino acid residues to the stationary phase can result in their presence
in MS. Development of non-sorption based purification and enrichment methods would
be ideal. Yeung’s group has been successful in developing a method to selectively
sample and enrich phosphorylated peptides using capillary electrophoresis (CE) [43,44,
1]..
In the technique developed in Yeung’s group, phosphorylated peptides are •
selectively sampled from the bulk sample by utilizing the fact that phosphorylated
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peptides tend to have lower iso-electric points than non-phosphorylated peptides [43].
Thus at low pH, the phosphopeptides would have a greater probability of bearing a net
negative charge while non-phosphorylated peptides (with a higher pi) would be more
likely to be either neutral or possess a net positive charge. By utilizing this information,
phosphopeptides can be selectively migrated into a capillary while the neutral and
positive peptides remain in the sample vial. This sampling method has been used to
isolate phosphopeptides from non-phosphorylated peptides even with the concentration of
non-phosphopeptides at 1 million times greater than the desired analyte [43,44]. In
addition, an attomole detection limit was achieved when selective sampling was
combined with matrix assisted laser desorption/ionization (MALDI) with nanoliter
volume sample spots [43,44].
The selective sampling method was then integrated with an enrichment step [1].
In this method, enrichment was achieved by using a technique called stacking. Sample
enrichment by stacking occurs when there is a sudden reduction in the mobility of the
analyte. One method of reducing the mobility of the analyte is to change the conductivity
o f the running buffer; called field amplified stacking (FASS). A change in conductivity
can be achieved by introducing a zone with low conductivity where injection takes place;
a plug of water is often used. The analyte ions will have a higher mobility in the plug of
water and therefore migrate faster in this zone. When the ions reach the boundary
between the water plug and the running buffer they will slow down and stack as they
cross the boundary. In the work reported by Zhang et al. a plug of water was injected to
create the zone of low conductivity (Figure 2.2 A) [1]. The analytes were then
selectively injected based on their pI, stacked at the water-buffer boundary (Figure 2.2
B), and then electrophoresis based on the size-to-charge ratio was performed (Figure 2.2

C). The analytes were then spotted onto a MALDI target in nano-liter volume spots
(Figure 2.2 D). The integrated procedure yielded an enrichment factor of 600 [1].

A: Water plug introduced to create a zone of low conductivity

H20

Buffer

B: Selective injection of anions and mobility reduction at the water-buffer
boundary resulting in stacking

C: Electrophoretic separation of anions based on their size-to-charge ratio

D: Sample spotting onto MALDI target

Figure 2.2: The integrated procedure of selective injection, sample stacking, and
electrophoresis o f phosphopeptides reported by Zhang et al in ref [ 1].
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The work presented herein is similar to that which was presented by Zhang et al in
that selective injection was used to introduce the desired analytes into the capillary. The
difference between the two methods lies in the technique used to enrich the peptides.
While both methods utilize stacking techniques the previous work uses field strength to
alter the mobility of the analytes and the method presented here uses a pH boundary to
change the ionization state of the analytes which alters their mobility. In the work
presented here the analytes were selectively injected based on their p/ (Figure 2.3 A) and
then acidic (pH 3) and basic (pH 9.75) buffers were placed at the inlet and outlet,
respectively, to create two pH junctions at each end of the capillary (Figure 2.3 B).
Enrichment occurred due to stacking at the pH junctions. At the pH 3 and pH 5 junction,
anions with a pi between 3 and 5 would be trapped and enriched. If they migrated into
the pH 3 buffer they would become positively charged (since the pH was less than the pi)
and migrate back to the pH 5 zone (Figure 2.3 C). At the other junction (pH 5 and pH
9.75) the opposite effect was occurring: any analyte migrating into the pH 9.75 buffer
become more negatively charged and migrate back into the pH 5 zone (Figure 2.3 C).
The migration of the pH junction moved the enriched analyte zone toward the detector
which was then spotted on a MALDI target for MS analysis (Figure 2.3 D).
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A: Selective injection of anions from sample vial

+
r—— V
pH 5
Buffer

P <33
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pH 5
Buffer

Buffer

B: Creation of two pH junctions

G
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0
©

pH 3
Buffer

pH 5
Buffer

—

®
^,75
Buffer

C: Enrichment of analytes
pH 5

D: Electrophoresis of enriched analytes toward detector

pH 3
Buffer

pH 9.75
Buffer

Figure 2.3: The integrated procedure of selective injection, sample enrichment, and
electrophoresis of peptides followed by spotting on a MALDI target presented in this
thesis.
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2.2 Experimental Section

2.2.1 Apparatus

.. .

All selective injection and enrichment experiments were performed using an
Agilent 3D-CE Capillary Electrophoresis Instrument (Palo Alto, CA, USA). Direct UV
absorbance detection was performed at 254 nm for mesityl oxide (EOF marker) and 200
nm for peptides. Data acquisition was enabled by the use of the ChemStation software
provided by Agilent. Fused silica capillaries were purchased from Polymicro
Technologies (Phoenix, AZ, USA). The dimensions of the capillaries were 50 pm I.D
(inner diameter), 360 pm O.D (outer diameter), 48.5 cm in total length, and 40 cm to the
detector window. The capillaries were thermostated at 25 °C. Mass spectral data was
obtained using a Bruker Reflex IV MALDI time-of-flight (TOF) mass spectrometer
(Bremen/Leipzig, Germany). The instrument was equipped with a 3 ns 337 nm nitrogen
laser. Reflectron and positive ion mode were used. Mass spectra were recorded as sums
of 50 individual laser shots using video monitoring. Igor Pro (WaveMetrics, Lake
Oswego, OR, USA) was used for data processing and presentation of mass spectral and
CE data.
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2.2.2 Chemicals and Reagents

Zwitterionic surfactants 1,2-dimyristoyl-s«-glycero-3 -phosphocholine (DMPC,
C14) and 1,2-dimyristoyl-stt-glycero-3 -phosphate (DMPA, C13) were obtained from
Avanti Polar Lipids, Inc. (Alabaster, AL, USA). The phospholipid solutions were
prepared as 0.1 mM solutions in 20 mM Tris-HCl at pH 7.2 with 20 mM calcium chloride
as previously reported [45]. Calcium chloride is used to promote the formation of the
phospholipid bilayer on the silica surface. Briefly, the 0.1 mM solutions were sonicated
for 10 min and then allowed to cool to room temperature with stirring. This cycle was
repeated until a clear, colourless solution was observed. The DMPC and DMPA were
then mixed at the appropriate ratio and subjected to the sonicate/stir procedure until a
clear, colourless solution was observed. All solutions were prepared using 18.2MG
deionized water from a Millipore Water Purification System (Bedford, MA, USA).
ACS grade phosphoric acid, ammonium hydroxide, sodium hydroxide, formic
acid, and hydrochloric acid were purchased from EM Science (Gibbstown, NJ, USA).
OmniTrace grade glacial acetic acid was also purchased from EM Science. Mesityl
oxide, ammonium citrate, tris(hydroxymethyl)aminomethane (tris), ammonium
bicarbonate, and 2,5-dihydroxybenzoic acid (DHB) were purchased from Sigma Aldrich
(Markham, ON, Canada). Calcium chloride and HPLC grade methanol were purchased
from Caledon (Georgetown, ON, Canada). ACS grade acetone was obtained from
Fischer Scientific Ltd. (Nepean, ON, Canada). Ethanol (95%) was purchased from
Commercial Alcohols, Inc. (Brampton, ON, Canada).
Adrenocorticotropic hormone fragment 18-39 (ACTH, MW 2465.7, p/4.25),
angiotensin I (AI, MW 1296.5, p i 6.92), and bradykinin (BK, MW 1060.2, p / 12.00) were
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purchased from Sigma Aldrich. The iso-electric points were calculated using an online pi
calculator provided by ExPASy [46].

2.2.3 EOF Suppression and Measurement

Controlling the EOF to prevent non-selective injection of the sample solution is of
utmost importance in ensuring the success of the selective injection. With the
experimental set-up used an EOF in the forward direction (cathodic) is required. A
reversed EOF (anodic) would not allow for selective sampling injection since the
direction would be from the vial into to the capillary and all peptides in the sample would
be injected. In addition to the direction, the magnitude of the EOF must be controlled.
An EOF which is too fast would not allow the peptides to migrate into the capillary.
Thus, the direction and magnitude of the EOF must be controlled to allow the maximum
amount of peptides to be selectively injected. The magnitude of the EOF can be
suppressed by using a coating to cover the silanol groups. Since detection will be done
with MS, a zwitterionic phospholipid semi-permanent coating called DMPC was chosen.
The direction of the EOF at the selective injection pH 5 was reversed. To change the
direction of the EOF to forward a negative phospholipid, DMPA was added to the coating
solution. The coating used was a mixture of DMPC and DMPA which has previously
been found to be effective in ensuring a forward EOF at acidic pH [47,43]. At pH 5 a
mixture of DMPC and DMPA (90:10 mole ratio) was used to generate a suppressed
forward EOF.
Each new capillary was pre-conditioned using high pressure (1 bar) in the
following sequence: 0.1 M HC1 for 10 min, water for 10 min, 0.1 M NaOH for 10 min,
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water for 10 min, and then the mixture of DMPC and DMPA for 20 min. Prior to each
run, the coating was reapplied using high pressure for 10 min followed by a 3 min rinse
with the selective injection buffer (50 mM acetic acid pH 5, adjusted with ammonium
hydroxide). New capillaries and coating solutions were prepared every 5 days to ensure a
reproducible EOF.
The EOF was measured using Williams and Vigh’s three-injection method [48].
Briefly, two mesityl oxide peaks were injected at a known distance apart. An electric
field was then applied for a set time enabling the EOF and mobilizing the two mesityl
oxide peaks. After voltage application a third mesityl oxide peak was injected followed
by low pressure to push all three peaks to the detector. The EOF can be calculated using
the following formula:
_ (ti + t3'2t2)V Ld
t oltLt
t3

Equation 2.1

The migration times of the mesityl oxide peaks are given by tj, k, and t$, in their elution
order (in s). V is the electric field applied to the capillary (in volts); Lt is the total
\

capillary length while Ld is the length to the detector (both in cm). Finally, tvonis the
length of time voltage was applied for (in s). EOF measurements were performed in
replicates of three at each pH. Mesityl oxide (20 mM) was used as an EOF marker.
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2.2.4 Selective Injection with Optical Detection

During selective injection with optical detection, the analyte solution (200 pL in
buffer) was placed at the detector end of the capillary (8.5 cm to detector) with a buffer
vial at the other end of the capillary (40 cm to detector). Injection of ACTH was achieved
by applying +10 kV for 2 min and to inject AI and BK -10 kV for 2 min was used. After
selective injection the peptides were mobilized to the detector using vacuum (-20 mbar).
In addition to selective injection, each peptide was hydrodynamically injected (-20 bar for
1 min) and then mobilized to the detector using vacuum (-20 mbar). The concentration of
each peptide was 0.1, 0.15, and 0.2 mg/mL for ACTH, AI and BK, respectively.

2.2.5 Evaluation of Peptide Enrichment Using UV Detection

To analyze the enrichment step, the capillary was filled with basic buffer (10 mM
ammonium adjusted to pH 9.75 with acetic acid), then 0.05 mg/mL ACTH in pH 5 buffer
(5-50 mM acetic acid adjusted with ammonium hydroxide) was hydrodynamically
injected to fill about 1/3 of the capillary volume, and finally acidic buffer (10 mM
formate adjusted to pH 3 with ammonium hydroxide) was hydrodynamically injected to
fill about 1/3 o f the capillary volume. At the boundary between the ammonium and
acetate buffer, as well as between the acetate and formate buffer a small amount of
mesityl oxide (MO) was injected (20 mbar, 3 sec) to mark the location of the pH
junctions. Voltage was then applied (20 kV) for varying lengths of time (0-10 min).
After voltage application, low pressure was used (20 mbar) to mobilize the contents of the
capillary to the detector to visualize the enrichment.
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2.2.6 Simulation of Enrichment Using SIMUL5

The simulation computer program is available as a free download from [49]. This
program is able to predict the movement of electrolytes during electrophoresis. For the
purpose of this work, the run parameters were as follows: injection site, 15 mm; peak
width 10 mm; peak edge width, 0.01 mm, EOF, 0; capillary diameter, 50 pm; capillary
length 48.5 mm; voltage 200 V; and temperature, 25 °C. All other parameters were left at
default values. The three buffers were simulated as follows: formate buffer, 10 mM
formate and 0.5 mM ammonium; acetate buffer, 50 mM acetic acid and 31.74 mM
ammonium; and ammonium buffer, 10 mM ammonium and 2.35 mM acetic acid.

2.2.7 Selective Injection and Enrichment with MALDI MS Analysis

Selective injection was performed by placing the peptide solution at the outlet end
of the capillary (the detector end) with a buffer vial placed at the other end (inlet). The
volume of the peptide solution was 200 pL in all experiments. To inject ACTH or the
i
\
low p/peptides from the a-casein digest a positive potential (+10 kV) was applied. After
selective injection was complete, the outlet end of the capillary (which was in the peptide
solution) was immersed in HC1 for 2 seconds and then the selective injection buffer (50
mM acetic acid) for 2 seconds to remove any excess peptide solution. To perform the
enrichment step an acidic buffer (10 mM formate) was placed at the inlet and a basic
buffer (10 mM ammonium hydroxide) at the outlet. A positive potential of +20 kV was
applied until a sharp peak was seen at the detector (30-40 min). Once the peak passed the
detector, the capillary was placed in a modified cassette to facilitate analysis by MALDI

57
MS (Figure 2.4). The modified cassette placed one end of the capillary outside the
instrument which allowed the contents of the capillary to be spotted onto a MALDI
target. The contents of the capillary were deposited onto a steel MALDI target in 25 nL
droplets (50 mbar for 15 sec). The MALDI target was pre-spotted with DHB matrix. The
DHB matrix was used in a three-layer method for MALDI analysis [50]. Briefly, 0.5 pL
o f a 20 mg/mL DHB in methanol/acetone (1:1 v/v) solution was deposited onto the target
followed by 0.1 pL of a 20 mg/mL DHB solution in 25 mM ammonium
citrate/water/ethanol/phosphoric acid (60:19:20:1 v/v/v/v). After the first two layers were
dry, the sample solution from the capillary was used as the third layer.

Figure 2.4: Schematic of spotting contents of capillary onto a MALDI target for MS
detection.
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2.3 Results and Discussion

2.3.1 Electroosmotic Mobility

Previously in the Yeung group the phospholipids DLPC and DMPC had been use
to suppress the EOF over a wide pH range [51-54]. However, in this work a pH of 5
resulted in a reversed EOF which would not allow for selective injection of anions with
the experimental setup used. Instead a suppressed forward (or cathodic) EOF was
required for selective injection of anions at pH 5. In order to generate a suppressed
forward EOF a negative charge must be introduced to the capillary wall. To achieve this
a solution of DMPC and DMPA was used [1]. DMPA is similar to DMPC except instead
of a zwitterionic group it possesses a phosphate (Figure 1.5 D). A ratio of 90:10 (mole
ratio) yielded an average EOF of 1.62x10' cm /V-s which was found to be satisfactory
for selective sampling at a pH of 5.

2.3.2 Evaluation of Selective Injection with UV Detection

Selective injection was evaluated using the UV-vis detector on the CE instrument.
The sample was injected using voltage (electrokinetic injection) and then mobilized to the
detector using low pressure. In a separate experiment, each peptide was
hydrodynamically injected and mobilized to the detector with low pressure in order to
obtain the absorbance of the original sample solution. Since the peptides would be
detected at the same wavelength (200 nm), and therefore not differentiated, separate
sample solutions were prepared and subjected to the selective sampling conditions. The
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peptides chosen for this study were ACTH (MW: 2465.7 g/mol, p/4.25), AI (MW: 1296.
g/mol, p7 7.00), and BK (MW: 1060. g/mol, p712.00). To selectively inject anions
(ACTH), the sample was placed at the cathode. The direction of the EOF was forward
(into the sample vial) and only negative ions would migrate into the capillary with the
cationic peptides (AI and BK) remaining in the sample vial. Figure 2.5 A shows the
signals detected from electrokinetic injection of the peptides. As anticipated, the only
signal observed corresponds to ACTH. The height of the selectively injected ACTH peak
was similar to that of the hydrodynamically injected peak (~ 6.5 mAU) which suggests
there is little sample loss. In order to show that the cations can be selectively injected, the
polarity of the voltage was reversed; sample placed at the anode. This resulted in the
selective injection of AI and BK only (Figure 2.5 B).

Absorbance (mAU)
peptides, A) sample at cathode (10 kV, 2 min) and B) sample at anode (-10 kV, 2
min). Mobilized to detector with -20 mbar and detected at 200 nm. Peptide
concentrations: (-----) 0.1 mg/mL ACTH, (— -) 0.15 mg/mL BK, (----- ) 0.2
mg/mL AI. Peptides were dissolved in 50 mM acetate buffer at pH 5.
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The mobility of ACTH was higher than the EOF and therefore did not migrate into the
capillary. The peak heights of electrokinetically injected AI and BK were also close to
the hydrodynamically injected peaks (~ 13 mAU and 8 mAU, respectively). The
difference in the peak lengths of AI and BK can be attributed to differences of their
mobility.

2.3.3 Evaluation of Enrichment Using UV Detection

To evaluate just the enrichment step a plug of ACTH in 50 mM pH 5 acetate
buffer was injected between plugs of acid (10 mM pH 3 formate) and base (10 mM pH
9.75 ammonium) buffer as shown in Figure 2.6. The theoretical p /o f ACTH is 4.25;
therefore the peptides should be present as anions in the acetate buffer. It is anticipated
that the anions will migrate toward the pH junction between the pH 3 and pH 5 buffers.
The p /o f the peptides should allow them to be trapped at the pH junction as zwitterions.
As the formate buffer titrates the acetate buffer, it is expected that the pH junction will
migrate toward the cathode with the enriched peptides trapped at the pH junction. The
first electropherogram (Figure 2.6 A) shows the initial setup with no voltage application.
The subsequent electropherograms show the contents of the capillary after 2,4, 8, and 10
minutes of voltage application (Figure 2.6 B-E).
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Figure 2.6: Electropherograms showing the enrichment of ACTH (— -) in 50 mM
acetate buffer at various time points: A) 0 min, B) 2 min, C) 4 min, D) 8 min, and
E) 10 min. Mesityl oxide
) marks the initial location of the pH junctions
between the acetate buffer and 10 mM formate buffer pH 3 (right side) and 10 mM
ammonium pH 9.75 (left side).
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After 2 min of voltage application (Figure 2.6 B) the ACTH begins to accumulate
at the end of the sample plug; between the pH 3 and pH 5 buffers. With increasing
voltage application time, the intensity of the peak increased (Figure 2.6 C and D). After
10 min of voltage application the peptide peak moved out of the initial sample zone and
the shouldering was eliminated (Figure 2.6 E) which suggests the enrichment was
completed. At the other pH junction (between pH 5 and pH 9.75) there was some
enrichment present. This can be attributed to the anionic ACTH peptides migrating
slowly toward the anode. The band broadening is attributed to the use of pressure to
mobilize the peaks past the detector.
A computer program was used to simulate the enrichment portion of the
experiment in order to validate the enrichment method [49]. The program, called
SIMUL5 mathematically models the migration of electrolytes during electrophoresis [55,
56]. The program was setup as described in Section 2.2.6. The initial conditions inside
the capillary are shown in Figure 2.7 A. The left side of the plot represents the inlet and
is where the formate buffer is located. Next, the sample zone with the 50 mM acetate
buffer and on the right side is the outlet with the ammonium buffer. The sample zone was
placed closer to the inlet than performed experimentally because the peptides moved
toward the outlet. The next three plots (Figure 2.7 B-D) show the contents of the
capillary after 30, 240, and 600 seconds, respectfully. As the voltage application time
increases, the sample zone decreases in size and migrates toward the outlet, which agrees
with the experimental results. In order to get a better visualization of the changes in pH,
just the pH was plotted at the same time points (0, 30,240, and 600 seconds, respectfully)
in Figure 2.8 A-D. It is important to focus on the pH because its changes are responsible
for enrichment. The simulation revealed several pieces of information about the
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enrichment step. The first is that between the pH 3 and pH 5 buffers a zone of
electrophoretically adjusted buffer with a pH of 3.07 (Figure 2.8 B-D) and a composition
of 62.32 mM acetic acid and 0.43 mM ammonium (Figure 2.7 B-D) is formed.
Secondly, between the pH 3 buffer and the adjusted buffer of pH 3.07 a zone of pH 3.53
(Figure 2.8 B-D) and composition of 7.89 mM acetic acid and 0.15mM ammonium
(Figure 2.7 B-D) is formed; this broadens with increasing voltage application time. It is
interesting to note that this zone is created where the initial pH junction between the pH 3
and pH 5 buffers was. The formation of these electrophoretically adjusted buffer zones is
due to the movement of the acetate and ammonium ions toward the anode and cathode,
respectively. Between the pH 5 and pH 9.75 buffers the pH junction remains sharp and
no electrophoretically modified zones are created.
In the pH 3.07 buffer it is predicted the ACTH peptides would change their
ionization (from negative to positive) and migrate as cations toward the outlet (cathode).
Enrichment is due to the charge reversal and subsequent mobility change at the boundary
between the pH 3.07 and pH 5 buffers. However, from the simulation data, there also
seems to be additional stacking due to a change in conductivity. The conductivity in the
pH 5 buffer is much higher than in the rest of the capillary (the black trace in Figure 2.7).
The reason for the high conductivity is that the pH 5 buffer was prepared using 50 mM
acetate. Thus when the ACTH peptides reach the boundary between the pH 3.07 and pH
5 buffers they not only experience a charge reversal, their mobility is also decreased by
the increase in conductivity.

B

Concentration (mM), Conductivity (10'2 S/m), pH

A

Figure 2.7: SIMUL5 computer simulation results of pH ( —-), conductivity (——),• formate concentration (— - ), acetate
concentration
and ammonium concentration ( — ) during enrichment at various time points: A) 0 s, B) 30 s, C) 240 s,
and D) 600 s.
<3Y

U\

Figure 2.8: SIMUL5 computer simulation results of pH during enrichment at various time points: A) 0 s, B) 30 s, C) 240 s,
and D) 600 s.
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The small amount of enrichment observed at the pH junction between pH 5 and
pH 9.75 (Figure 2.6 B-D) is due to the increase in conductivity in the pH 5 buffer. If a
peptide moves into the pH 9.75 buffer the amount of negative charge will increase (since
the pH is much higher than the pI) and the peptide will move back to the pH 5 buffer.
, Since the conductivity is higher in the pH 5 buffer, the ions slow down resulting in
stacking.
The results of the simulation are similar to what was initially thought to occur
during enrichment. The peptides in the pH 5 selective injection buffer should be
negatively charged and therefore migrate toward the anode. The simulation revealed that
an electrophoretically adjusted buffer would with a pH of 3.07 which would alter the
ionization state of the peptides once they migrated out of the pH 5 buffer. The peptides,
now cations, would then change direction and migrate toward the cathode and become
enriched at the pH junction between the pH 3.07 and pH 5 buffers. In addition to pH
mediated stacking, the pH 5 buffer had a much higher conductivity than the rest of the
buffers. Resulting in field amplified stacking as well since the peptides would have a
higher mobility in the pH 3.07 buffer than in the pH 5 buffer.
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2.3.4 Combining Selective Sampling and Enrichment with MALDI MS Analysis

To evaluate the integrated procedure of selective sampling and enrichment using
two pH junctions, a solution of ACTH, AI, and BK was used. The sample solution was
placed at the outlet (peptides in 50 mM acetate buffer, pH 5) and selective injection was
performed (10 kV, 5 min) then a formate buffer (10 mM formic acid, pH 3) vial was
placed at the inlet and an ammonium buffer (10 mM ammonium, pH 9.75) vial was
placed at the outlet. Voltage was applied (20 kV, 30 min) to enrich the peptides. After
30 min of voltage application low pressure (20 mbar) was used to mobilize the peak to the
detector. The electropherogram of the enrichment portion of the experiment is shown in
Figure 2.9 with the sharp peak anticipated to be enriched ACTH.

Figure 2.9: Electropherogram of selective injection coupled to enrichment of
a solution of 0.05 mg/mL ACTH, AI, and BK in 50 mM acetate at pH 5.
Experimental conditions: selective injection 5 min 10 kV followed by 20 kV
for 30 min then 20 mbar until peak seen.
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Figure 2.10: MALDI MS spectra of A) the original sample mixture injected and
spotted hydrodynamically and B) the 11th MALDI spot of the integrated procedure,
Conditions: sample placed at cathode and selective injection performed (10 kV, 5
min) followed by enrichment (20 kV, 30 min, then 20 mbar); ACTH, AI, and BK
concentration: 0.05 mg/mL; MS: reflectron and positive ion mode, 25 nL spot
volumes.
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The results of MS analysis of the sharp peak seen in the electropherogram are
shown in Figure 2.10 A-B. Even though there were some of the unwanted peptides
present in the MALDI spectra, the ACTH was enriched (Figure 2.10 A-B). The average
peak height of ACTH before enrichment was 3100 and after it was 9500, leading to an
enrichment factor of 3. The enriched ACTH was spread over two main spots (data not
shown) with subsequent spots having lower and lower intensities. It was hoped that the
small spot volume (25 nL) would enable the enriched peptide to be contained in a single
MALDI spot. Broadening due to the use of pressure to spot onto the MALDI target and
the difficulty of capturing the enriched peptide in a single spot contributed to the peak
being spread over two spots.
While the selective injection was successful in keeping the bradykinin from
entering the capillary it appears that some AI was present in the spots with ACTH. Since
the selective sampling step was performed at the same end of the capillary as spotting, it
is possible that some of the peptides adsorbed onto the outside of the capillary and were
deposited onto the MALDI target during spotting. It was for this reason that the outlet of
the capillary was submerged in a vial of acid (0.1 M HC1) and then buffer (50 mM
acetate, pH 5) prior to the enrichment step. It was found that this effectively reduced the
intensity of AI.
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2.4 Conclusions

Through the use of UV-Vis detection it has been shown that selective injection is
successful in allowing the migration of the desired anions into a capillary. The results
agreed with what had been previously reported [54]. The enrichment of the ACTH
peptides was then investigated using UV-Vis detection and enrichment was observed
within 10 minutes of voltage application.
A simulation program was used to model the enrichment portion of the
experiment. It was found that two electrophoretically altered buffer zones were created
with voltage application due to the movement of the buffer ions. One formed inside the
sample zone and had a pH of 3.07 and was composed of 62.32 mM acetic acid and 0.43
mM ammonium. The other zone formed at the initial location of the pH junction between
the pH 3 and pH 5 buffers. This electrophoretically generated buffer had a pH of 3.53
and was composed of 7.89 mM acetic acid and 0.15 mM ammonium. The enrichment
step was found to occur in a similar way to what was initially thought. The ACTH
peptides (p/4.25) would be negatively charged in the pH 5 selective injection buffer and
migrate toward the anode. Once they crossed the pH junction between the pH 5 and pH
3.07 buffers they would become cations and reverse direction toward the cathode. The
enrichment would be due to the charge reversal at the pH junction between pH 5 and pH
3.07. The simulation also revealed stacking due to a change in conductivity. The initial
buffer which the peptides were in (50 mM acetate pH 5) had a high conductivity while the
pH 3.07 buffer had a relatively low conductivity. Thus, any peptides which were in the
pH 3.07 buffer would experience a drop in mobility at the boundary between the pH 3.07
and pH 5 buffers.
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The integrated method of selective sampling and enrichment yielded promising
results when it was tested with a peptide mixture of ACTH, AI and BK. This technique is
ready to be tested with phosphorylated peptides. A possible first choice would be to use a
proteolytic digest of a- or 0- casein.

i
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Chapter 3: In-Capillary Derivatization: Towards Methyl Esterification
of Phosphopeptides
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3.1. Introduction

Protein phosphorylation is one of the most common post-translational
modifications and is involved in many cellular signaling and regulatory mechanisms [1].
However, detection of phosphorylated peptides by MS is relatively challenging, not only
due to their low abundance but also due to ion suppression from non-phosphorylated
peptides. As mentioned in Chapter 2, there has been considerable effort in enhancing the
signal of phosphopeptides in MS. This has included additives to the MALDI matrix such
as ammonium salts and phosphoric acid [2-5]. Another approach was to chemically
modify the phosphate group to increase ionization efficiency [6]. In addition to
increasing the detection of phosphorylated peptides there has been a need to isolate
phosphorylated peptides from other non-phosphorylated peptides in the sample. Most of
the techniques involve sorption where the phosphate shows some affinity for the
stationary phase and becomes bound temporarily. The unwanted peptides pass through
the column then the phosphorylated peptides are released and collected. The most
commonly used methods are immobilized metal affinity chromatography and metal oxide
affinity chromatography [7-12].
Immobilized metals are used to selectively retain phosphorylated peptides, but this
method suffers from non-specific binding of carboxylate groups from acidic amino acid
residues. One method to solve this problem is to esterify the carboxylate groups on all
peptides including aspartate and glutamate and the C-terminus. This is known to reduce
non-specific binding of non-phosphorylated peptides on immobilized metal.
Mass spectrometry has emerged as an indispensable tool in proteomics. Its high
sensitivity, low detection limits, and label-free detection technique make it an excellent
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tool for analysis of proteins and peptides. While MS analysis requires sub-pL sample
volumes and is able to detect very small quantities of sample (less than an attomole),
traditional sample handling, purification, and concentration techniques are limited to
relatively large volumes of samples (mL to pL). This imposes an unnecessary increase in
sample requirement for the total analysis, including sample handling. An effective way to
downsize the handling steps therefore becomes especially important. Miniaturization of
the sample concentration steps also has the benefit of increasing the sensitivity in MS
detection. The need for miniaturization has led to the development of microfluidics and
ultimately lab-on-a-chip devices.
Microfluidics presents the logical choice for the manipulation of very small
volumes; usually in the range of nanoliters (nL) down to femtoliters (fL) and even
attoliters (aL) [13]. These small volumes are controlled using pumps, valves, and
electrodes which allow for mixing, separation, and digestion to be performed in the micro
channels. One of the main advantages of microfluidic devices is the reduced sample,
reagent, and solvent used which in turn reduces the amount of waste produced, relative to
a full-scale instrument. Another advantage is if several steps in an analysis were
performed on a single microfluidic device; for example concentration of the sample,
separation, and then detection using MS. The amount of sample handling would be
greatly reduced allowing for more reproducible results, less sample loss due to adsorption
and contamination during sample handling. As more of the analysis becomes integrated
on a microfluidic device, to the point where the entire analysis can be performed, the term
lab-on-a-chip (LOC) can be used. Commercially available fully integrated LOC do not
yet exist for proteomics. Most of the research in the area of microfluidics and LOC for
proteomics has been into the development of single function chips and interfacing to MS.
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Fully integrated LOC devices are still in the early stages of development with research
still to be done before this technique becomes more widely used. LOC devices also have
to compete with traditional, well established instruments and techniques. A switch from
traditional methods to microfluidics and LOC devices would require a significant
advantage and/or lower costs. As mentioned above, most of the research has been
focused on single function chips coupled to MS detection; the single function is usually a
separation. This leaves the difficult task of integrating sample derivatization and/or
concentration onto a chip along with separation and detection.
In many cases a full scale instrument is used to develop methods for
miniaturization. Capillary electrophoresis (CE) is an appropriate technique to investigate
method development for LOC and microfluidic devices. Some of the attractive features
of CE for miniaturization are: low volumes inside the capillary, samples can be
manipulated with either pressure or voltage, many techniques exist for concentration, and
the instrument can be coupled with MS detection. Several separation modes and
concentration methods used in CE have already been scaled down for use on microfluidic
devices [14-18]. While CE has been used extensively as a separation technique, it is also
well suited for sample preparation.
Yeung’s group has focused mainly on sample preparation studies performed in
aqueous media. There are some sample preparations which must be performed in nonaqueous conditions. Sample preparation in-capillary under non-aqueous conditions has
been very limited. There are a few publications which use large volume sample stacking
(LYSS) which was developed in aqueous CE [19]. This concentration method has been
used in non-aqueous conditions to concentrate parabens and p-hydroxybenzoic acids with
sensitivities in the ng/mL range [20,21]. The work presented here are efforts toward inJ
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capillary methyl esterification of phosphopeptides in non-aqueous conditions. A general
réaction scheme is shown below in Figure 3.1.

HC1

MeOH

O
HC1 +

MeOH

+

HC1

Figure 3.1: Schematic showing the general methyl esterification reaction. The
top reaction shows the formation of anhydrous HC1 in methanol. The bottom
reaction shows the methyl esterification of a generic carboxylic acid.

Performing the methyl esterification reaction in-capillary would have the
advantage of consuming a small amount of peptide sample, aiding in the miniaturization
of the reaction. In addition, once inside the capillary and esterified, the CE instrument
could then be coupled to MALDI MS for detection. The two main types of MS ionization
used in proteomics are matrix assisted laser desorption/ionization (MALDI) and
electrospray ionization (ESI) because their ionization mechanism is ‘soft’ and does not
extensively fragment proteins and peptides. In general, MALDI is used over ESI in CE
and there are several reasons but the main ones are: the ease of coupling to the instrument
and being able to spot a portion of the volume inside a capillary.
The work presented here aims to investigate and hopefully resolve a number of
challenges associated with in-capillary methyl esterification. The first challenge is the
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extremely acidic reaction conditions which can potentially damage the instrument
components. It may also generate exceedingly high current when voltage is applied. A 1
second challenge is that the reaction must be performed in a water-free environment due
to side product formation. The solvent used in the reaction is methanol and it readily
absorbs water from the atmosphere so extra care must be taken to ensure minimal water
contamination. Additionally, since the reaction must be performed in non-aqueous
conditions the capillary wall cannot be coated. Many coatings are extremely sensitive to
the presence of organic solvents and are often severely degraded if not completely
removed from the capillary wall. With these challenges in mind, the reaction will first be
performed in the traditional way of in-vial. In order to determine the compatibility of the
CE instrument with the reaction conditions, the reactants will be mixed prior to being
injected into a capillary and then allowed to react. The length of time required for the
reaction to proceed as well as the sensitivity of the reaction will then be investigated. The
advantages of in-capillary reaction over conventional in-vial reactions will be carefully
examined. Once this has been established, performing the reaction in-capillary will be
investigated by using various sample introduction and mixing techniques. The findings
will determine future directions in manipulating the migration (introducing and removal)
of various reagents for a series of in-capillary reactions.
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3.2. Experimental Section

3.2.1 Apparatus

All measurements of methanolic-HCl solutions in an applied electric field were
performed on a Beckman Coulter P/ACE MDQ Capillary Electrophoresis Instrument
(Fullerton, CA, USA) and all in-capillary reactions without voltage application and
spotting from capillary onto a MALDI target were performed with an Agilent 3D-CE
Capillary Electrophoresis Instrument (Palo Alto, CA, USA). Data acquisition was
performed using the Beckman P/ACE System MDQ software or ChemStation software
by Agilent. Uncoated fused-silica capillaries were purchased from Polymicro
Technologies (Phoenix, AZ, USA). The capillary dimensions were 50 pm in inner
diameter, 360 pm in outer diameter with a total length of 50 or 40 cm, and the detection
window at 40 or 30 cm, respectively, from the inlet. During runs, capillaries were
thermostated at 25 °C. Mass spectrometry data was obtained using a Bruker Reflex IV
MALDI Time-of-Flight (TOF) mass spectrometer (Bremen/Leipzig, Germany). The
instrument was equipped with a 3 ns 337 nm nitrogen laser. Reflection and positive ion
mode were used. Igor Pro (WaveMetrics, Lake Oswego, OR, USA) was used for data
processing.
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3.2.2 Chemicals and Reagents

Anhydrous methanol was purchased from Sigma Aldrich (St. Louis, MO, USA)
and was used in methyl esterification reactions and voltage tests. Acetyl chloride was
purchased from Fluka and was used as a source of protons in the methyl esterification
reaction. Angiotensin IF (Sigma Aldrich) was used as a model peptide due to its low cost
and two possible sites of methyl esterification. 2,5 dihydroxybenzoic acid (DHB) (Sigma
Aldrich) was used as the matrix for MALDI. Water was deionized by a Millipore
purification system (Bedford, MA, USA). Myoglobin (horse heart) was obtained from
Sigma Aldrich.

3.2.3 Capillary Preconditioning

Prior to use, a new capillary was flushed (1 bar) with anhydrous methanol for 30
min. The typical capillary pre-treatment of flushing the capillary with sodium hydroxide,
water, coating (if applicable), and running buffer was not employed due to the presence of
water in these solutions. Any water present during methyl esterification would lead to
formation of side products. Between runs, the capillary was flushed with anhydrous
methanol for at least 30 min. After use, the capillary was flushed with anhydrous
methanol for 30 min and stored with the ends of the capillary in vials of methanol.
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3.2.4 Methyl Esterification

The methanolic-HCI solution was prepared using a literature procedure [22]. In
short, 160 pL of acetyl chloride was added drop-wise to 1 mL of anhydrous methanol.
The reaction was allowed to stir for 5 min at room temperature before being used. When
larger volumes of methanolic-HCI were needed, this procedure was scaled up,
maintaining the same acetyl chloride to anhydrous methanol ratio. Fresh solutions of
methanolic-HCI were prepared each day.

3.2.4.1 In-Vial Methyl Esterification

In-vial reactions were performed by adding methanolic-HCI to angiotensin II
(All) dried (SpeedVac) in a 0.6 mL PCR vial. The vial was then capped and the reaction
i

allowed to proceed at room temperature for the desired length of time. Once the reaction
time was reached, the reaction mixture was evaporated using a SpeedVac. The peptides
were then reconstituted in water and spotted on double-layered DHB spots for MALDI
MS analysis and comparison to in-capillary reactions.

3.2.4.2. In-Capillary Methyl Esterification

The in-capillary reactions using the Agilent instrument was performed in the same
way as the first step in 3.2.4.1 (methanolic-HCI was added to a vial containing All). The
reaction mixture was then injected into a capillary using low pressure (50 mbar) for 10
min. Since the reaction mixture was very acidic, injection had to be performed from
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outside the CE instrument to avoid damage to the electrodes and interior of the
instrument. The setup was similar to that used for spotting the products on a MALDI
target as shown in Figure 3.4. Instead of the MALDI target at the outlet, the vial of
reaction mixture was placed on a riser, which was at the same level as the inlet end of the
capillary, and vacuum was used to inject some reaction mixture into the capillary. Once
injection was complete, the capillary was returned to the cassette and placed in the
instrument for the duration of the reaction with the ends of the capillary in methanol vials.
After the reaction time was reached, the contents of the capillary were spotted onto
double-layered DHB matrix for MALDI MS analysis and comparison to in-vial methyl
esterification.

3.2.5 Performing Reactant Mixing Inside a Capillary

The mixing of reactants inside the capillary was performed using the Beckman
P/ACE CE instrument. The capillary was first flushed (1 bar) for 30 minutes with
anhydrous methanol to remove and traces of water from inside the capillary. After the
\

MeOH-HCl was prepared, it was flushed (1 bar) through the capillary for 30 minutes. To
mix the reactants, the capillary was first filled with MeOH-HCl and then a short plug of
peptide dissolved in methanol (15 s, 20 mbar) was injected followed by MeOH-HCl (15 s,
20 mbar). This sequence was repeated until there were ten plugs each of MeOH-HCl and
peptide. The set of plugs was then mobilized to the centre of the capillary with low
pressure. When voltage was used to mix, positive polarity voltage was applied for 1
minute then negative polarity voltage was applied for 1 minute. This swapping of voltage
polarity was repeated 28 times. When pressure was used to mix the plugs, positive
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pressure and vacuum were alternated to afford mixing 28 times. Once the mixing was
finished, the reaction was allowed to proceed for one hour. After one hour, the capillary
was removed from the Beckman instrument and transferred to an Agilent CE instrument
for spotting onto a MALDI target (discussed below).

3.2.6 MALDI Conditions and Spotting from Capillary

Detection of the reaction products from in-capillary reactions was performed by
direct spotting of the contents of the capillary onto a MALDI target in 0.2 pL fractions,
using a matrix of layered DHB, with MALDI MS detection in TOF-R mode. A
schematic of this method is shown in Figure 3.2. Briefly, once the reaction is complete,
the outlet is placed outside the instrument and low pressure was used to mobilize the
product toward the outlet where it was spotted onto the MALDI target. The DHB was
prepared from a literature procedure and applied to the MALDI target in two layers (0.5
pL base layer, and 0.2 to 0.05 pL top layer, then sample) [23]. Calibration was
performed using an in-house tryptic digest of Myoglobin (horse heart). Detection of
esterification products was limited to ions between 300 and 4000 m/z. Each MS
spectrum shown is a sum of 100 laser shots, unless otherwise noted.

CE instrument

Figure 3.2: Schematic of spotting contents of capillary onto a MALDI target for
MS detection.
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3.3 Results and Discussion

3.3.1 Degree of Methyl Esterification with Varying Reaction Times

The length o f time it takes the reaction to go to completion was investigated.
Some procedures reported conversion to fully esterified product in less than an hour with
side product and sample degradation occurring with longer reaction times [24], Others
reported longer reactions sometimes followed by evaporation of the reaction mixture and
repeating the reaction [25,26]. The difference in reaction times is likely due to the
number of carboxyl groups in the starting material. Peptides with only a few sites for
esterification take less time to fully esterify while peptides which are larger and have
more possible sites for esterification take more time and potentially several rounds of
esterification.
For the initial experiments a model peptide was chosen instead of using a
phosphorylated protein digest. The peptide chosen was angiotensin II (All) due to its low
cost and the presence of two esterification sites.

3.3.1.1. In-Vial Reaction Time

The in-vial reaction was performed by adding MeOH-HCl to dried angiotensin II.
The contents of the vial were then shaken and allowed to react for various amounts of
time. Once the reaction time was reached, the MeOH-HCl was removed (lyophilized)
and the subsequent dry peptides were re-constituted in water prior to MS analysis. The
in-vial reaction times are shown in Figure 3.3. The peaks present after the labeled peak
in the figures represent the isotopic distribution of AIL The labeled peak shows the

monoisotopic peak. In this figure, the uppermost MS spectrum shows the starting
material, angiotensin II (All), before the addition of methanolic-HCl. The only peak
present corresponds to un-esterified All at 1046 m /z.A peak at 1060 m/z represents
singly esterified All and a peak at 1074 m/z corresponds to doubly (fully) esterified All.
The progression of the reaction was observed every twenty minutes for one hour and then
once more after four hours.

Figure 3.3: Mass spectra of the in-vial reaction mixture under various reaction times.
The sequence of All is shown and the bold purple denotes esterified amino acids.
Conditions: 50 pL of MeOH-HCl added to vial of dried peptides. Reaction proceeded
for the desired length of time then spotted on MALDI target.
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The reaction proceeds quickly, after twenty minutes there was no starting material
and a large peak representing the full esterification of All appeared. It appears that after
one hour the reaction has gone to completion with longer reaction times showing the
reappearance o f single ester. Since the reaction is reversible and water is a side product
of the reaction, it is possible that the generation of water during the reaction is responsible
for the small amount of single ester reforming.
The short reaction time for most of the peptide to become fully esterified may be
attributed to the peptide’s small size (8 amino acids) and having only two possible sites
for esterification. When this work is extended to more complex samples the reaction time
may need to be adjusted. However, for work with All, a reaction time of one hour will be
used for all subsequent in-vial reactions.

3.3.1.2 In-Capillary Reaction Time

The set-up for the in-capillary reaction was different than for the in-vial method.
The procedure started out the same way: MeOH-HCl was added to dry angiotensin II and
then shaken. Next, the reaction mixture was injected into a capillary using pressure. The
reaction was allowed to proceed and then the contents of the capillary were spotted
directly onto a MALDI target for MS analysis. Since there was some time required for
the reaction mixture to be injected into the capillary, it was difficult to obtain short
reaction times, for this reason the shortest reaction time was half an hour. The mass
spectra in Figure 3.4 show the results from different reaction times performed in
capillary.

Figure 3.4: Mass spectra of in-capillary reaction mixtures over various reaction
times. The sequence of All is shown and the bold purple denotes esterified amino
acids. Conditions: 50 pL of MeOH-HCl was added to a vial of dried peptides. The
reaction mixture was then injected into a capillary. Once desired reaction time had
elapsed the contents of the capillary were spotted onto a MALDI target for MS
analysis. ■
'
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The uppermost mass spectrum shows the starting material (1046 m/z). There is
very little starting material present after half an hour and most of the All has been fully
esterified. After one hour of reaction, there appears to be no remaining starting material
and a very small amount of singly esterified product present with the majority being fully
esterified. Reaction times of two and four hours do not show an increase in fully
esterified AIL The in-capillary method appears to follow the same trend as the in-vial
method.
There appears to be less formation of singly esterified peptide formed in-capillary
than with the in-vial method. A plausible explanation is that when the reaction is
performed in-capillary the reaction mixture does not come into contact with as much
water from the air because the ends of the capillary are placed in vials of methanol for the
duration of the reaction. In an attempt to remove any water present in the capillary it was
flushed with methanol for at least 30 minutes prior to injection of the reaction mixture.
The in-capillary method allows for spotting of the reaction mixture directly from the
capillary onto a MALDI target.
An advantage to performing the reaction inside a capillary is that the reaction
mixture does not need to be removed prior to MS analysis. This is because the spot
volume with the in-capillary method (50 nL) was much smaller than with the in-vial
method (0.25 pL). With a smaller spot volume, there was less spreading of the MeOHHC1 and MS spectra could be collected. When the reaction mixture was spotted using a
pipette (0.25 pL) the pre-spotted matrix was dissolved and it was impossible to obtain MS
data.

94
3.3.2 Degree of Methyl Esterification with Varying All Concentration

The reaction was first attempted using a high concentration of AIL The
concentration of All was then decreased to get an idea of the sensitivity. Three
concentrations of All were chosen to be tested 2.0, 0.2, and 0.02 pg/mL. The reaction
was performed at each concentration both in-vial and in-capillary with a one hour
reaction time.
The mass spectra of the results using 2.0 pg/mL are shown in Figure 3.5. The left
mass spectrum shows the reaction products in-capillary and the right mass spectrum
shows the in-vial products. This concentration yielded high intensity peaks and a very
good signal-to-noise ratio (S/N).

1074

m/z
Figure 3.5: Mass spectra of in-capillary and in-vial methyl esterification
of 2.0 pg/mL AIL
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The next concentration of AITtested was 0.2 pg/mL. The mass spectra of the
results are shown in Figure 3.6, with the in-capillary method on the left and the in-vial on
the right. The intensities are much lower than with the previous concentration but the S/N
is still high.
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Figure 3.6: Mass spectra of in-capillary and in-vial methyl esterification
of 0.2 pg/mL AIL
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The mass spectra in Figure 3.7 show results from the in-capillary and in-vial
methods with 0.02 pg/mL of AIL The most obvious difference between the two spectra
is that there are no peaks present with the in-vial method. The most probable explanation
for this is that when using such a low concentration of peptide there is significant
adsorption to the sides of the vial. Even though the vials used were designed to reduce
the adsorption of sample, it still occurs to some degree. A second possibility is that there
is some sample loss/degradation of the peptides during the lyophilization step when the
in-vial method is used.
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Figure 3.7: Mass spectra of in-capillary and in-vial methyl esterification
of 0.02 pg/mL AIL
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Another possibility is the sample was not found when MALDI analysis was
performed. This is one of the disadvantages of using MALDI MS, samples can
congregate in ‘hot spots’ that are sometimes difficult to find. Another disadvantage of
using MALDI is for the analysis of small amounts of sample: the matrix spots are usually
quite large and finding the sample can be tedious. A solution to this is to prepare matrix
spots that are very small so the area for the sample to be deposited is much smaller. It is
because o f these disadvantages that this particular amount of reactant was run several
more times than the other amounts. In all of the runs performed, there were no peaks
seen for the in-vial method.
One of the trends apparent in all three of the concentrations used was that the in
capillary method consistently had higher intensity peaks. In the case of the lowest
concentration of All used (0.02 pg/mL) there were no peaks seen when the reaction was
performed in-vial. Here we find another advantage to using the capillary as a reaction
vessel: a lower limit of detection is achieved.

i
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3.3.3 Performing the Methyl Esterification Reaction Inside a Capillary

Up until this point the reactants were mixed prior to injection into a capillary
essentially using the capillary as a small vial. Since there were advantages to performing
the reaction inside a capillary, the next step was to investigate methods of mixing the
peptide with the MeOH-HCl inside a capillary. It was determined the best way to
introduce the peptides and MeOH-HCl would be to have the capillary filled with MeOHHC1 and then inject the peptides. The two could then be mixed using either voltage or
pressure. Injecting a large plug of peptide into the MeOH-HCl would probably not result
in a complete reaction. So, the peptides and MeOH-HCl were injected in alternating
plugs which were 1 cm long with 10 of each plug for a total of 20 plugs (Figure 3.8).

Peptides in
Methanol

MethanolicHC1

MethanolicHC1

t

Methanolic-HCl
Figure 3.8: Schematic o f in-capillary reaction with alternating bands of methanolicHC1 and peptides dissolved in methanol. The bands would be mixed by using either
voltage or pressure.

c
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3.3.3.1 Using Voltage to Mix the Peptide and MeOH-HCl

Mixing the peptide and MeOH-HCl was first tried using voltage. The peptides
dissolved in methanol and the MeOH-HCl were injected into a capillary in alternating
plugs as depicted in Figure 3.8. Since applying only one polarity of voltage would move
everything out of the capillary, positive and negative polarity voltage was applied for 1
minute and then switched to the opposite polarity; this switching was repeated 14 times.
The reaction was then allowed to proceed for one hour and then the contents of the
capillary spotted onto a MALDI target. There were peptides present in four consecutive
spots and the MS data from those four spots are shown in Figure 3.9 A-D.

Intensity
Figure 3.9: MALDI mass spectra of the four consecutive spots (A, B, C, D) from mixing the reactants inside a capillary
using voltage. The peak at 1046 m/z is starting material (All); 1060 m/z represents a peptide with a single ester; and 1074 m/z
represents a peptide which has been fully esterified. Conditions: 50 nL was spotted onto MALDI target pre-spotted with
DHB. Each spectrum is a sum of 100 individual shots

o
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The MS data show that using voltage to mix was not able to afford successful mixing of
the reactant plugs. It is possible that the high current generated during voltage application
did not allow the protons to migrate very fast. If this was the case, then they would not
penetrate very far into the peptide band. Since using voltage was not successful in
successful mixing using pressure to mix the reactants was investigated.

3.3.3.2 Using Pressure to Mix the Peptides and MeOH-HCl

The next option would be to use pressure to mix the peptides with the MeOHHC1. The setup was the same as when voltage was used for mixing. In the same way the
polarity of the voltage was alternated, the pressure was switched between pressure and
vacuum to mix the bands together. There were peptides present in four consecutive
MALDI spots and the results are shown in Figure 3.10 A-D. From the MS spectra it
appears that mixing was not successful.

Intensity

m/z

':

Figure 3.10: MALDI mass spectra of the four consecutive spots (A, B, C, D) from mixing the reactants inside a capillary
using pressure. The peak at 1046 m/z is starting material (All); 1060 m/z represents a peptide with a single ester; and 1074
m/z represents a peptide which has been folly esterified. Conditions: 50 nL was spotted onto MALDI target pre-spotted with
DHB. Each suectrum is a sum of 100 individual shots
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From the MS data, the mixing methods used were not successful. It was hoped that by
alternating the injection of peptide and MeOH-HCl bands better mixing would be
achieved. Even after a reaction time of 1.5 hours (mixing + 1 hour reaction time) there
was still starting material left. It is difficult to determine causes for the poor mixing of
the reactants. One possible reason is that the amount of voltage used (when voltage was
used to mix) was not enough to allow the protons to migrate into the peptide plugs. Since
there was such a high concentration of HC1 the voltage was limited due to the high
current generated.
It is unlikely the methanol used to dissolve the peptides contributed to dilution of
the MeOH-HCl. To prepare the MeOH-HCl, 160 pL of acetyl chloride was added to
1000 pL of methanol. Therefore the addition of several more nanoliters of methanol
would not likely have a major effect on the concentration of the anhydrous HC1.
Another possibility is the dimensions of the capillary. With such a small i.d. (50 pm)
there simply may not have been enough room for effective mixing to take place. A
potential remedy for this would be to use a capillary with a larger i.d. however this would
make spotting onto MALDI target difficult. By using a larger i.d. it would be more
difficult to spot a small volume and when methanol is spotted onto a MALDI target it
spreads out quite a bit. Even spotting a volume of 50 nL of methanol from a 50 pm i.d.
capillary produces a much larger spot than the same volume of water. The other problem
with spotting methanol is that if too much is spotted, it will dissolve the two layers of
matrix already deposited on the target. The result is that the matrix becomes so thin that
is becomes impossible to generate any data.
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3.4 Conclusions

Testing the reaction in-vial and in-capillary revealed two advantages of the in
capillary method over the in-vial. The first is that removal of the MeOH-HCl prior to
spotting on a MALDI target was not required for the in-capillary method; the reaction
mixture can be spotted directly from the capillary onto the MALDI target. The reason for
this is the spot volume was much smaller when using a capillary (50 nL) than with a
pipette for the in-vial method (0.25 pL). The smaller spot volume did not completely
dissolve the pre-spotted matrix and allowed for MS analysis. With the in-vial method, the
larger spot volume essentially dissolved the pre-spotted matrix and made MS analysis
impossible. Therefore, the MeOH-HCl had to be removed and the peptides reconstituted
in water to obtain MS data. The second advantage was that a lower detection limit was
achieved with the in-capillary method. The most likely explanation for this is that during
lyophilization some of the peptides were lost and/or degraded. Since the in-capillary
method did not require lyophilization, there was less sample loss.
Thè in-capillary method was used to gauge the effectiveness of the capillary as a
reaction vessel. There was no voltage used in the experiments. Since there were
advantages to performing the reaction in-capillary, mixing the reactants inside the
capillary was investigated. The peptide and MeOH-HCl were injected in alternating
bands in an attempt to facilitate their mixing. Two mixing methods were examined:
mixing with voltage and mixing with pressure. It turned out that using either voltage or
pressure was not effective in mixing the reactants. Since the goal was to utilize the
capabilities of the CE instrument (use voltage to manipulate the sample) the project was
left at this point and not investigated further.
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4.1 Conclusions
\

.

Over the past decade or so mass spectrometry has been the detection method of
choice for protein and peptide identification due to its label-free detection, user
friendliness and high throughput capabilities. However, low abundance peptides often
have their signals suppressed by those with higher abundances. It is for this reason that
sample purification and preconcentration steps prior to MS analysis have become
important. Since the acidic phosphate group on phosphorylated peptides reduces
ionization efficiency, these sample preparation steps prior to MS analysis are especially
important. This thesis investigated two different techniques related to the analysis of
phosphorylated peptides. While they focused on different sample pretreatments the
general goal was to improve the signal intensity of the desired analytes.
Integration of selective sampling of peptides based on pI followed by enrichment
using a pH junction was attempted. The use of a phospholipid surfactant to coat the
capillary was essential to allow for selective sampling under the chosen conditions. A
computer program was used to simulate the enrichment portion of the experiment. It was
A

discovered that enrichment was achieved by both pH mediated and field amplified
stacking. Integrating selective injection and enrichment was successful in selecting and
enriching an acidic peptide from a mixture.
The miniaturization of a methyl esterification reaction was also attempted.
Preliminary experiments using a capillary as a reaction vessel were promising. It was
found that mixing the reactants together and then injecting them into a capillary had
advantages over the traditional in-vial method: lyophilization of the MeOH-HCl was not
required and a lower detection limit was achieved. However, when mixing the reactants
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inside a capillary was attempted using both voltage and pressure, there was not sufficient
mixing to allow for a complete reaction to take place; One of the goals of this project was
to use electrophoresis to manipulate the reactants. Since mixing with voltage was not
successful there was no further investigation in this project.

4.2 Future Work

The next step in the integrated procedure of selective sample injection and
enrichment would be to use the method on a phosphorylated peptide sample. If
successful with phosphorylated peptides it would be interesting to see if the method could
be applied to other post translational modifications where there is a change in p/when the
PTM is added. An example of such is the sulfation of tyrosine, threonine, and serine
amino acid residues [1-3]. Similar to phosphorylation, sulfation lowers the p/ of the
peptide due to its acidic nature [4, 5]. It has been found that this modification has been
present at sites where protein-protein interactions take place as well as affecting many
other biological functions which has greatly increased interest in studying this PTM [6].
Due to the p7 change when the sulfate group is added to the peptide, it should be possible
to selectively sample the sulfated peptides. With the correct selection of buffers the
enrichment should also be feasible.
There are some ideas to try with the methyl esterification reaction. One would be
to decrease the size of the sample and MeOH-HCl plugs. This would hopefully allow for
complete mixing of the two reactants. Another idea would be to continually switch the
polarity of the voltage for the duration of the reaction. Once the conditions were
optimized, the reaction could be tested on digest of a phosphorylated protein.
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One of the main advantages of using CE techniques over traditional
chromatographic techniques is its use of voltage. This is especially true when adapting
techniques for use on microfluidic devices. Voltage driven techniques are desired over
pressure techniques since there would be no need for pumps. It is hoped that the sample
preparation and separation techniques developed by Yeung’s group will be miniaturized
and integrated onto a microfluidic device. In recent years there has been intensive
research into coupling micro fluid devices to MS [7, 8] and progress toward lab-on-a-chip
[9-11]. Continued efforts from Yeung’s group as well as many other researchers are
required to realize the goal of a lab-on-a-chip to analyze an entire proteome.

Ill
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